These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 18344087)
1. [Prognostic value of cyclin E and its relation to blood vessel invasion in rectal cancer]. Zhou YJ; Wan FL; Yao LH; Feng LY Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):167-71. PubMed ID: 18344087 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer. Zhou YJ; Xie YT; Gu J; Yan L; Guan GX; Liu X Eur J Surg Oncol; 2011 Dec; 37(12):1078-84. PubMed ID: 21944050 [TBL] [Abstract][Full Text] [Related]
3. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy. Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229 [TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of cyclin E expression in operable breast cancer. Potemski P; Kusińska R; Pasz-Walczak G; Piekarski JH; Watała C; Płuciennik E; Bednarek AK; Kordek R Med Sci Monit; 2009 Feb; 15(2):MT34-40. PubMed ID: 19179977 [TBL] [Abstract][Full Text] [Related]
5. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression. Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer. Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer. Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195 [TBL] [Abstract][Full Text] [Related]
10. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma. Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403 [TBL] [Abstract][Full Text] [Related]
11. Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy. Sogawa N; Takiguchi N; Koda K; Oda K; Satomi D; Kato K; Ishikura H; Miyazaki M Int J Oncol; 2002 Oct; 21(4):787-93. PubMed ID: 12239617 [TBL] [Abstract][Full Text] [Related]
12. [Correlation of invasion, metastasis, and prognosis in low and middle rectal cancer]. He WJ; Wang L; Hu H; Kang SY; Qian HX; Xu FM Ai Zheng; 2002 Nov; 21(11):1222-5. PubMed ID: 12526220 [TBL] [Abstract][Full Text] [Related]
13. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection]. Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079 [TBL] [Abstract][Full Text] [Related]
14. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer. Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy. Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192 [TBL] [Abstract][Full Text] [Related]
16. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer. Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma. Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708 [TBL] [Abstract][Full Text] [Related]
18. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival. Bréchot JM; Chevret S; Charpentier MC; Appere de Vecchi C; Capron F; Prudent J; Rochemaure J; Chastang C Cancer; 1996 Nov; 78(10):2111-8. PubMed ID: 8918404 [TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients. Meng WJ; Sun XF; Tian C; Wang L; Yu YY; Zhou B; Gu J; Xia QJ; Li Y; Wang R; Zheng XL; Zhou ZG Oncology; 2007; 72(1-2):82-8. PubMed ID: 18004081 [TBL] [Abstract][Full Text] [Related]
20. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer. Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]